[Artificial Intelligence. Photo Credit to Pixabay]

On July 14, 2026, Nature Biotechnology published an article explaining how artificial intelligence (AI) is reshaping the future of animal testing.

The article highlighted new technologies such as AI, organoids,  and organs-on-chips that may reduce the need for laboratory animals in drug development.

Rather than replacing animal testing by itself, AI could play a pivotal role by analyzing data from these different technologies and helping scientists better predict how drugs will affect humans. 

This raises an important question: Could AI eventually help reduce the necessity of animal testing? 

For decades, scientists have relied on animal testing for new drug development.

This crucial step helped researchers find possible side effects and understand how a drug moves through the body.

Medicines rarely affect just one organ.

They travel through the bloodstream, are changed by the liver, removed by the kidneys, and may also affect the heart, brain, or immune system.

Because all of these organs work together, animals have been useful in studying the whole body at once.

However, animals are not humans.

Although mice, rats, and monkeys share many biological features with humans, their bodies do not work exactly the same way.

A medicine that is safe for a mouse may not be safe for a person.

Conversely, a drug that causes problems in an animal may work well in humans.

Because of these differences, scientists have been searching for better ways to predict how the human body will respond to new medicines.

One exciting development is called an organoid.

Organoids are tiny human tissues grown from stem cells that mimic some features of real organs.

Scientists can use these organoids to test how human tissues respond to different drugs, giving AI more human-based data to analyze.

Another promising technology is the organ-on-a-chip.

Organs-on-chips place human cells in small devices that can copy conditions such as blood flow and interactions between tissues.

These models can provide AI models with more realistic information about how drugs may affect the human body.

AI can integrate information from these different technologies and help scientists predict drug safety.

By analyzing large amounts of past drug data, AI can identify patterns linked to harmful effects and predict whether a new drug may cause similar problems.

It can also analyze results from organoids and organs-on-chips, helping scientists decide which drug candidates are safer and which ones may require more testing.

In this way, AI could reduce some animal experiments rather than simply replacing them all entirely. 

Despite these advancements, one important challenge remains.

Scientists must prove that these methods are accurate and reliable.

Imagine that an animal study says a drug is dangerous, but an AI program predicts it is safe.

What results should researchers believe?

New technologies cannot replace older methods simply because they are newer.

They must show that they can predict human health outcomes accurately and consistently.

Regulatory acceptance is also crucial before these technologies can truly reduce animal testing in drug development.

Even if an AI model or organoid produces promising results, drug developers need regulatory approval, such as from the U.S. Food and Drug Administration, to accept the evidence when deciding whether a drug can move forward.

In 2026, the FDA released new guidance outlining how these modern testing methods should be evaluated. 

The goal is not simply to stop using animals, but to ensure that any alternative is reliable enough to protect people in clinical trials.

If AI-based methods can meet this standard, they could gradually reduce the need for some animal studies. 

The future of drug development will likely integrate many different tools, with AI helping connect and analyze their results.

Organoids and organs-on-chips can provide human-based experimental data, while AI can help scientists find patterns and predict possible risks.

However, animal studies may still be necessary when these newer methods cannot provide sufficient evidence. 

Animal testing is unlikely to disappear completely overnight.

However, as AI continues to improve and scientists gain deeper insights into human biology, the role of animal experiments may gradually diminish.

The real goal is not simply to replace animals with computers.

The ultimate goal is to develop safer medicines by understanding the human body more accurately.

AI may not replace animal testing entirely, but it could help change when and how often it is needed.